Analyst Ratings for Bio-Rad Labs (BIO)
BIO Rating Summary
BIO Price Target Summary
- Highest: $437.00 (RBC Capital)
- Lowest: $325.00 (UBS)
- Average: $367.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$367.33 (+36.1%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/1/2024 | Citi » Updated 2/14/2025 |
Patrick Donnelly | Upgrade | Buy (Neutral) |
400.00 (450.00) |
334.58 (269.85) |
-19.35% | Details |
| 8/28/2024 | Nephron | Jack Meehan | Upgrade | Buy (Hold) |
390.00 (N/A) |
319.37 (269.85) |
-15.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
